Glycoprotein IIb/IIIa Receptor-directed Monoclonal Antibodies
DBCAT005708Pharmacologic class
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of November 29, 2022
Which targets do Glycoprotein IIb/IIIa Receptor-directed Monoclonal Antibodies share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account